pubrio
Asymchem logo

Asymchem

Public
asymchem.com
Pharmaceuticals700+ employeesFounded 1999🇨🇳 China

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

Founded
1999
Employees
700+
Industry
Pharmaceuticals
Company type
Public Company
Stock
sse: 06821.HK
Headquarters
🇨🇳6 Dongting 3rd Avenue, Teda, Tianjin Municipality, Cn, 300457 (+9)
Specialties
PharmaceuticalsBiotechnologyChemical Manufacturing
2 / 3
Active markets
United States · United Kingdom · India
0
New markets
Low
Confidence
mostly early signals
+1000%
Momentum
vs prior period
33 / 100
Expansion Score
Developing
Stages3Investing
12 signals · Last 90 days

Global expansion

Live
United StatesUnited KingdomIndia
Stages
ExploringInvestingLandingOperating

Activity pulse

New Marketing & PR activity — 11 fresh signals just appeared.

Last 90 days
Hiring
1Ended
Hiring
Marketing & PR
11New
Advertising
Product & Tech
0
No activity
+2more categoriesLocked
3 of 5 shown

Market entry timeline

The order this company entered each market — oldest to newest

1
🇺🇸United States1st market entered · 2012Advancing
Investing
16 signalsInvesting stage
2
🇬🇧United Kingdom2nd market entered · 2024Advancing
Investing
14 signalsInvesting stage
3
🇮🇳India3rd market entered · 2025Advancing
Investing
1 signalInvesting stage
Current stageInvestingCommitting resources
Confidence33%Low
Tracking since2012first signal

Recent signals

Advertising🇵🇹 Portugal4w ago

Asymchem Basel Symposium

Advertising🇺🇸 United States4w ago

Asymchem Basel Symposium

Sign up to see the full signal feed

Good to know

Frequently Asked Questions Regarding Asymchem

Quick answers about Asymchem's business, markets, and growth signals.

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

© 2026 Pubrio. All rights reserved.